Trisomy 21: from chromosomes to mental retardation
- PMID: 16596471
- DOI: 10.1007/s10519-006-9052-0
Trisomy 21: from chromosomes to mental retardation
Abstract
The first descriptions of the trisomy 21 phenotype were by Jean-Etienne-Dominique Esquirol (1838), Edouard Séguin (1846) and later by John L. H. Down in 1862. It took more than a century to discover the extra-chromosomal origin of the syndrome commonly called "Down's syndrome" and which, we suggest, should be referred to as "Trisomy 21". In this review we are presenting the landmarks, from the pioneering description of the syndrome in 1838 to Jérôme Lejeune's discovery of the first genetic substrate for mental retardation. The sequencing of HSA21 was a new starting point that generated transcriptome studies, and we have noted that studies of gene over-expression have provided the impetus for discovering the HSA21 genes associated with trisomy 21 cognitive impairment.
Similar articles
-
Mouse models of cognitive disorders in trisomy 21: a review.Behav Genet. 2006 May;36(3):387-404. doi: 10.1007/s10519-006-9056-9. Epub 2006 Mar 8. Behav Genet. 2006. PMID: 16523244 Review.
-
Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.Behav Genet. 2006 May;36(3):416-28. doi: 10.1007/s10519-006-9053-z. Epub 2006 Mar 24. Behav Genet. 2006. PMID: 16557362 Review.
-
Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.Eur J Paediatr Neurol. 2008 May;12(3):168-82. doi: 10.1016/j.ejpn.2007.08.010. Epub 2007 Oct 22. Eur J Paediatr Neurol. 2008. PMID: 17933568 Review.
-
Functional analysis of genes implicated in Down syndrome: 1. Cognitive abilities in mice transpolygenic for Down Syndrome Chromosomal Region-1 (DCR-1).Behav Genet. 2004 Nov;34(6):559-69. doi: 10.1007/s10519-004-5584-3. Behav Genet. 2004. PMID: 15520513
-
Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.Genet Couns. 2007;18(2):217-26. Genet Couns. 2007. PMID: 17710874
Cited by
-
Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.Neuroscience. 2008 Sep 22;156(1):99-106. doi: 10.1016/j.neuroscience.2008.07.025. Epub 2008 Jul 25. Neuroscience. 2008. PMID: 18703118 Free PMC article.
-
Sleep-like behavior and 24-h rhythm disruption in the Tc1 mouse model of Down syndrome.Genes Brain Behav. 2015 Feb;14(2):209-16. doi: 10.1111/gbb.12198. Epub 2015 Feb 16. Genes Brain Behav. 2015. PMID: 25558895 Free PMC article.
-
Screening of Fetal Chromosome Aneuploidies in the First and Second Trimester of 125,170 Iranian Pregnant Women.Iran J Public Health. 2015 Jun;44(6):791-6. Iran J Public Health. 2015. PMID: 26258091 Free PMC article.
-
When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.Gene Expr. 2007;13(6):299-310. doi: 10.3727/000000006781510697. Gene Expr. 2007. PMID: 17708416 Free PMC article. Review.
-
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.Physiol Behav. 2017 Aug 1;177:230-241. doi: 10.1016/j.physbeh.2017.05.003. Epub 2017 May 3. Physiol Behav. 2017. PMID: 28478033 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical